Free Trial

Cameco Corporation (NYSE:CCJ) Shares Purchased by ORG Partners LLC

Cameco logo with Basic Materials background

ORG Partners LLC boosted its holdings in Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 7,236.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,538 shares of the basic materials company's stock after buying an additional 9,408 shares during the quarter. ORG Partners LLC's holdings in Cameco were worth $399,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Hurley Capital LLC acquired a new position in Cameco in the 4th quarter worth approximately $27,000. Bank Julius Baer & Co. Ltd Zurich acquired a new position in Cameco in the 4th quarter worth approximately $28,000. Whipplewood Advisors LLC acquired a new position in Cameco in the 4th quarter worth approximately $33,000. Compass Planning Associates Inc acquired a new position in Cameco in the 4th quarter worth approximately $36,000. Finally, Copia Wealth Management acquired a new position in Cameco in the 4th quarter worth approximately $39,000. Institutional investors and hedge funds own 70.21% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CCJ. Glj Research reaffirmed a "buy" rating and issued a $75.27 price objective on shares of Cameco in a research note on Thursday, June 12th. The Goldman Sachs Group lifted their target price on shares of Cameco from $65.00 to $78.00 and gave the company a "buy" rating in a research note on Wednesday, June 11th. Raymond James Financial reissued an "outperform" rating on shares of Cameco in a research note on Wednesday. Sanford C. Bernstein set a $70.00 target price on shares of Cameco and gave the company an "outperform" rating in a research note on Tuesday, June 10th. Finally, Royal Bank Of Canada lifted their target price on shares of Cameco from $90.00 to $100.00 and gave the company an "outperform" rating in a research note on Friday. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $77.30.

View Our Latest Report on CCJ

Cameco Stock Down 1.9%

CCJ stock opened at $68.33 on Friday. The company has a current ratio of 2.70, a quick ratio of 1.26 and a debt-to-equity ratio of 0.15. Cameco Corporation has a 1 year low of $35.00 and a 1 year high of $71.31. The company has a fifty day simple moving average of $53.72 and a 200 day simple moving average of $49.93. The firm has a market cap of $29.75 billion, a PE ratio of 170.83 and a beta of 0.97.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its earnings results on Thursday, May 1st. The basic materials company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.07). The firm had revenue of $549.58 million during the quarter, compared to the consensus estimate of $890.07 million. Cameco had a return on equity of 4.47% and a net margin of 7.50%. The business's revenue was up 24.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.13 EPS. Sell-side analysts anticipate that Cameco Corporation will post 1.27 EPS for the current fiscal year.

About Cameco

(Free Report)

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

Featured Stories

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cameco Right Now?

Before you consider Cameco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.

While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines